Literature DB >> 26914168

Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression.

Martin J Hoogduijn1, Samantha F H de Witte1, Franka Luk1, Mirjam C G N van den Hout-van Vroonhoven2, Lech Ignatowicz3, Rusan Catar4, Tanja Strini1, Sander S Korevaar1, Wilfred F J van IJcken2, Michiel G H Betjes1, Marcella Franquesa1, Guido Moll5,6, Carla C Baan1.   

Abstract

Mesenchymal stromal cells (MSC) are increasingly used as an investigative therapeutic product for immune disorders and degenerative disease. Typically, MSC are isolated from human tissue, expanded in culture, and cryopreserved until usage. The safety and efficacy of MSC therapy will depend on the phenotypical and functional characteristics of MSC. The freeze-thawing procedure may change these characteristics. Furthermore, the cells encounter a microenvironment after administration that may impact their properties. It has been demonstrated that the majority of MSC localize to the lungs after intravenous infusion, making this the site to study the effects of the in vivo milieu on administered MSC. In this study, we investigated the effect of freeze-thawing and the mouse lung microenvironment on human adipose tissue-derived MSC. There were effects of freeze-thawing on the whole genome expression profile of MSC, although the effects did not exceed interdonor differences. There were no major changes in the expression of hemostatic regulators on transcriptional level, but significantly increased expression of procoagulant tissue factor on the surface of thawed adipose MSC, correlating with increased procoagulant activity of thawed cells. Exposure for 2 h to the lung microenvironment had a major effect on MSC gene expression and affected several immunological pathways. This indicates that MSC undergo functional changes shortly after infusion and this may influence the efficacy of MSC to modulate inflammatory responses. The results of this study demonstrate that MSC rapidly alter in response to the local milieu and disease-specific conditions may shape MSC after administration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26914168     DOI: 10.1089/scd.2015.0329

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  25 in total

1.  Inducing Heat Shock Proteins Enhances the Stemness of Frozen-Thawed Adipose Tissue-Derived Stem Cells.

Authors:  Shahensha Shaik; Daniel Hayes; Jeffrey Gimble; Ram Devireddy
Journal:  Stem Cells Dev       Date:  2017-02-16       Impact factor: 3.272

2.  Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

Authors:  Raghavan Chinnadurai; Devi Rajan; Muna Qayed; Dalia Arafat; Marco Garcia; Yifei Liu; Subra Kugathasan; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Cell Rep       Date:  2018-02-27       Impact factor: 9.423

3.  Improved Post-Thaw Function and Epigenetic Changes in Mesenchymal Stromal Cells Cryopreserved Using Multicomponent Osmolyte Solutions.

Authors:  Kathryn Pollock; Rebekah M Samsonraj; Amel Dudakovic; Roman Thaler; Aron Stumbras; David H McKenna; Peter I Dosa; Andre J van Wijnen; Allison Hubel
Journal:  Stem Cells Dev       Date:  2017-03-15       Impact factor: 3.272

4.  Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome.

Authors:  Raghavan Chinnadurai; Matthew H Forsberg; John A Kink; Peiman Hematti; Christian M Capitini
Journal:  Curr Stem Cell Rep       Date:  2020-08-08

5.  Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation.

Authors:  Mingqi Zhang; Yan Zhao; Le Wang; Yuqiang Zheng; Hui Yu; Xiaoming Dong; Wei He; Zhengqin Yin; Zhuoshi Wang
Journal:  Cell Tissue Bank       Date:  2022-01-23       Impact factor: 1.522

6.  Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.

Authors:  Arjang Baygan; Wictor Aronsson-Kurttila; Gianluca Moretti; Babylonia Tibert; Göran Dahllöf; Lena Klingspor; Britt Gustafsson; Bita Khoein; Guido Moll; Charlotta Hausmann; Britt-Marie Svahn; Magnus Westgren; Mats Remberger; Behnam Sadeghi; Olle Ringden
Journal:  Front Immunol       Date:  2017-07-11       Impact factor: 7.561

7.  Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.

Authors:  Samantha F H de Witte; Ana M Merino; Marcella Franquesa; Tanja Strini; Johanna A A van Zoggel; Sander S Korevaar; Franka Luk; Madhu Gargesha; Lisa O'Flynn; Debashish Roy; Steve J Elliman; Philip N Newsome; Carla C Baan; Martin J Hoogduijn
Journal:  Stem Cell Res Ther       Date:  2017-06-08       Impact factor: 6.832

8.  Porcine Wharton's jelly cells distribute throughout the body after intraperitoneal injection.

Authors:  Kreeson Packthongsuk; Theresa Rathbun; Deryl Troyer; Duane L Davis
Journal:  Stem Cell Res Ther       Date:  2018-02-14       Impact factor: 6.832

9.  Effects of Normothermic Machine Perfusion Conditions on Mesenchymal Stromal Cells.

Authors:  Jesus M Sierra Parraga; Kaithlyn Rozenberg; Marco Eijken; Henri G Leuvenink; James Hunter; Ana Merino; Cyril Moers; Bjarne K Møller; Rutger J Ploeg; Carla C Baan; Bente Jespersen; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

Review 10.  Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation.

Authors:  Richard Heyes; Andrew Iarocci; Yourka Tchoukalova; David G Lott
Journal:  J Transplant       Date:  2016-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.